As a B Corp in the biopharmaceutical industry, Chiesi is counted among businesses that are leading a global movement for an inclusive, equitable, and regenerative economy. It is an achievement to be proud of, and yet one that feels natural: caring for others lies at the root of health science and has always been at the heart of our work.
While sustainability has always been important for Chiesi, today it is part of our strategic plan. It means we are committed to improve the quality of life of patients, to protect the planet and its inhabitants, to support our communities, to favour the development of our people and to guarantee the transparency of our work. As part of this process, we have chosen to become a B Corp and where possible a Benefit Corporation, an innovative legal status that allows us to serve a double purpose: not just creating value for our shareholders, but pursuing the general public benefit. Internally, we launched “ We Act - Actively Care for Tomorrow”, a sustainability program that engaged the whole Chiesi population into a coordinated effort.
Our B Corp certification is a truly global collective achievement. Since 2018, all the affiliates have been involved in a process of self-assessment and improvement, that led us to confirm our certification in 2022. Using standardised assessment criteria, we have been able to identify areas for potential development throughout the company and establish best practices to be extended to all our affiliates worldwide.
B Corps are companies that meet high standards of social and environmental performance, accountability, and transparency. The B Corp movement includes over 5,000 companies in more than 80 countries, whose common goal is to use business as a force for good. To become a B Corp, a company is required to achieve a minimum score on the B Impact Assessment, which is a rigorous assessment of the company’s impact on its workers, customers, community and environment. B Corps are also required to publish a yearly Impact Report for transparency.